These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Physiologic and pathophysiologic roles of endothelin in the kidney. Clavell AL; Burnett JC Curr Opin Nephrol Hypertens; 1994 Jan; 3(1):66-72. PubMed ID: 7850414 [TBL] [Abstract][Full Text] [Related]
3. Role of endothelin in renal function and dysfunction. Brooks DP Clin Exp Pharmacol Physiol; 1996 Apr; 23(4):345-48. PubMed ID: 8717072 [TBL] [Abstract][Full Text] [Related]
4. Role of endothelin and endothelin receptor antagonists in renal disease. Neuhofer W; Pittrow D Eur J Clin Invest; 2006 Sep; 36 Suppl 3():78-88. PubMed ID: 16919017 [TBL] [Abstract][Full Text] [Related]
6. Endothelins in the normal and diseased kidney. Kohan DE Am J Kidney Dis; 1997 Jan; 29(1):2-26. PubMed ID: 9002526 [TBL] [Abstract][Full Text] [Related]
7. Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology. Rabelink TJ; Kaasjager KA; Boer P; Stroes EG; Braam B; Koomans HA Kidney Int; 1994 Aug; 46(2):376-81. PubMed ID: 7967349 [TBL] [Abstract][Full Text] [Related]
8. Effect of nifedipine on cyclosporine A-induced nephrotoxicity, urinary endothelin excretion and renal endothelin receptor number. Brooks DP; Ohlstein EH; Contino LC; Storer B; Pullen M; Caltabiano M; Nambi P Eur J Pharmacol; 1991 Feb; 194(1):115-7. PubMed ID: 1647960 [TBL] [Abstract][Full Text] [Related]
9. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. Moore K; Wendon J; Frazer M; Karani J; Williams R; Badr K N Engl J Med; 1992 Dec; 327(25):1774-8. PubMed ID: 1435931 [TBL] [Abstract][Full Text] [Related]
10. The intrarenal endothelin system and hypertension. Abassi ZA; Ellahham S; Winaver J; Hoffman A News Physiol Sci; 2001 Aug; 16():152-6. PubMed ID: 11479363 [TBL] [Abstract][Full Text] [Related]
11. Renal functional impairment and sodium retention in liver cirrhosis. Gentilini P; Laffi G Digestion; 1989; 43(1-2):1-32. PubMed ID: 2680695 [No Abstract] [Full Text] [Related]
12. The renoprotective potential of endothelin receptor antagonists. Knoll T; Schaub M; Birck R; Braun C; Juenemann KP; Rohmeiss P Expert Opin Investig Drugs; 2000 May; 9(5):1041-52. PubMed ID: 11060726 [TBL] [Abstract][Full Text] [Related]
13. Defining the role of endothelins in renal pathophysiology on the basis of selective and unselective endothelin receptor antagonist studies. Benigni A Curr Opin Nephrol Hypertens; 1995 Jul; 4(4):349-53. PubMed ID: 7552102 [TBL] [Abstract][Full Text] [Related]
14. Paracrine renal endothelin system in rats with liver cirrhosis. Hocher B; Zart R; Diekmann F; Rohmeiss P; Distler A; Neumayer HH; Bauer C; Gross P Br J Pharmacol; 1996 May; 118(2):220-7. PubMed ID: 8735618 [TBL] [Abstract][Full Text] [Related]
15. Endothelin, angiotensin II and adenosine in acute cyclosporine A nephrotoxicity. Prévot A; Semama DS; Tendron A; Justrabo E; Guignard JP; Gouyon JB Pediatr Nephrol; 2000 Sep; 14(10-11):927-34. PubMed ID: 10975301 [TBL] [Abstract][Full Text] [Related]
17. Endothelin effects on renal function and tubuloglomerular feedback. Takabatake T; Ise T; Ohta K; Kobayashi K Kidney Int Suppl; 1991 Jun; 32():S122-4. PubMed ID: 1881035 [TBL] [Abstract][Full Text] [Related]
18. Endothelin and vascular function in liver disease. Moore K Gut; 2004 Feb; 53(2):159-61. PubMed ID: 14724140 [TBL] [Abstract][Full Text] [Related]
19. The paracrine endothelin system: pathophysiology and implications in clinical medicine. Hocher B; Thöne-Reineke C; Bauer C; Raschack M; Neumayer HH Eur J Clin Chem Clin Biochem; 1997 Mar; 35(3):175-89. PubMed ID: 9127739 [TBL] [Abstract][Full Text] [Related]
20. Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome. Wong F; Moore K; Dingemanse J; Jalan R Hepatology; 2008 Jan; 47(1):160-8. PubMed ID: 17886336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]